Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

967 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intravenous immunoglobulin for patients with unexplained recurrent implantation failure: a 6-year single center retrospective review of clinical outcomes.
Peero EK, Banjar S, Khoudja R, Ton-Leclerc S, Beauchamp C, Benoit J, Beltempo M, Dahan MH, Gold P, Kadoch IJ, Jamal W, Laskin C, Mahutte N, Phillips S, Sylvestre C, Reinblatt S, Mazer BD, Buckett W, Genest G. Peero EK, et al. Among authors: gold p. Sci Rep. 2024 Feb 16;14(1):3876. doi: 10.1038/s41598-024-54423-z. Sci Rep. 2024. PMID: 38365988 Free PMC article.
Immunomodulation for unexplained recurrent implantation failure: where are we now?
Genest G, Banjar S, Almasri W, Beauchamp C, Benoit J, Buckett W, Dzineku F, Gold P, Dahan MH, Jamal W, Jacques Kadoch I, Kadour-Peero E, Lapensée L, Miron P, Shaulov T, Sylvestre C, Tulandi T, Mazer BD, Laskin CA, Mahutte N. Genest G, et al. Among authors: gold p. Reproduction. 2023 Jan 4;165(2):R39-R60. doi: 10.1530/REP-22-0150. Print 2023 Feb 1. Reproduction. 2023. PMID: 36322478 Review.
Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
Banjar S, Kadour E, Khoudja R, Ton-Leclerc S, Beauchamp C, Beltempo M, Dahan MH, Gold P, Jacques Kadoch I, Jamal W, Laskin C, Mahutte N, Reinblatt SL, Sylvestre C, Buckett W, Genest G. Banjar S, et al. Among authors: gold p. Am J Reprod Immunol. 2023 Aug;90(2):e13737. doi: 10.1111/aji.13737. Am J Reprod Immunol. 2023. PMID: 37491929
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial.
Raghav KPS, Guthrie KA, Tan B Jr, Denlinger CS, Fakih M, Overman MJ, Dasari NA, Corum LR, Hicks LG, Patel MS, Esparaz BT, Kazmi SM, Alluri N, Colby S, Gholami S, Gold PJ, Chiorean EG, Kopetz S, Hochster HS, Philip PA. Raghav KPS, et al. Among authors: gold pj. J Clin Oncol. 2025 Jan 6:JCO2401710. doi: 10.1200/JCO-24-01710. Online ahead of print. J Clin Oncol. 2025. PMID: 39761503
Dealing With Complications as a Young Surgeon.
Gold P, Arshi A. Gold P, et al. Arthroplast Today. 2024 Jun 27;27:101419. doi: 10.1016/j.artd.2024.101419. eCollection 2024 Jun. Arthroplast Today. 2024. PMID: 39071839 Free PMC article.
967 results